A biopharmaceutical company that discovers, develops and manufactures antibodies and other genetically-engineered protein products to treat immunological and inflammatory disorders, cancer and infectious diseases.


Updates from The Motley Fool

Latest updates on XOMA from Fool.com.  The Fool has written over 100 articles on XOMA.
Is Xoma Corporation A Buy?

Xoma Corporation could release late stage trial data that could significantly move the stock.

Why XOMA Corp. Shares Tanked

XOMA shares take a tumble after reporting its first-quarter earnings results. Is this dip a buyin...

Why XOMA Corp. Shares Popped

XOMA shares zoom higher following a premarket upgrade from MLV & Co. Here's what investors should...

Down 30%, Worth a Look

XOMA falls after phase 2 trials fail, but its anti-inflammatory drug gevokizumab still has potent...



Stock Performance

View Interactive XOMA Charts
Sponsored by

Key Data Points

Primary metrics and data points about XOMA.
Current Price: $6.54
Prev Close: $6.04
Open: $5.95
Bid: $6.61
Ask: $6.75
Day's Range: $5.95 - $7.15
52wk Range: $3.96 - $19.00
Volume: 881,018
Avg Vol 167,699
Market Cap: $49M
P/E (ttm): -0.68
EPS (ttm): ($8.89)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about XOMA.
CAPS Rating 2 out of 5
 
331 Outperform
44 Underperform
CAPS All Stars
 
29 Outperform
19 Underperform

How do you think XOMA will perform against the market?



You pick for XOMA is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

John Varian, CEO

61% Approve

Based on 8 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for XOMA.

A biopharmaceutical company that discovers, develops and manufactures antibodies and other genetically-engineered protein products to treat immunological and inflammatory disorders, cancer and infectious diseases.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers